Investigating the candidacy of a lipoteichoic acid-based glycoconjugate as a vaccine to combat Clostridium difficile infection

Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccine

(2013) Christopher E. Martin et al.   CHEMICAL COMMUNICATIONS

Carbohydrate-based Clostridium difficile vaccines

(2013) Mario A Monteiro et al.   Expert Review of Vaccines

Immunological Evaluation of a Synthetic Clostridium difficile Oligosaccharide Conjugate Vaccine Candidate and Identification of a Minimal Epitope

(2013) Christopher E. Martin et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Evaluation of an Oral Suspension of VP20621, Spores of Nontoxigenic Clostridium difficile Strain M3, in Healthy Subjects

(2012) Stephen A. Villano et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Structural characterization of surface glycans from Clostridium difficile

(2012) Christopher W. Reid et al.   CARBOHYDRATE RESEARCH

A novel fusion protein containing the receptor binding domains of C. difficile toxin A and toxin B elicits protective immunity against lethal toxin and spore challenge in preclinical efficacy models

(2012) Jing-Hui Tian et al.   VACCINE

The Epidemiology of Community-Acquired Clostridium difficile Infection: A Population-Based Study

(2011) Sahil Khanna et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

A Possible Oligosaccharide-Conjugate Vaccine Candidate for Clostridium difficile Is Antigenic and Immunogenic

(2011) Matthias A. Oberli et al.   CHEMISTRY & BIOLOGY

Investigating the potential of conserved inner core oligosaccharide regions of Moraxella catarrhalis lipopolysaccharide as vaccine antigens: accessibility and functional activity of monoclonal antibodies and glycoconjugate derived sera

(2011) Andrew D. Cox et al.   GLYCOCONJUGATE JOURNAL

Meningococcal glycoconjugate vaccines

(2011) Roberto Gasparini et al.   Human vaccines & immunotherapeutics

Neutralization ofClostridium difficileToxin A with Single-domain Antibodies Targeting the Cell Receptor Binding Domain

(2011) Greg Hussack et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection

(2011) Lawrence J. Brandt et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

The host immune response to Clostridium difficile

(2011) C. P. Kelly et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Clostridium difficileinfection: update on emerging antibiotic treatment options and antibiotic resistance

(2010) Dhara Shah et al.   Expert Review of Anti-Infective Therapy

Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: immunology of glycoconjugates with high carbohydrate loading

(2010) Andrew D. Cox et al.   GLYCOCONJUGATE JOURNAL

Treatment with Monoclonal Antibodies againstClostridium difficileToxins

(2010) Israel Lowy et al.   NEW ENGLAND JOURNAL OF MEDICINE

First Synthesis ofC. difficilePS-II Cell Wall Polysaccharide Repeating Unit

(2010) Elisa Danieli et al.   ORGANIC LETTERS

Clostridium difficile cell-surface polysaccharides composed of pentaglycosyl and hexaglycosyl phosphate repeating units

(2008) Jeyabarathy Ganeshapillai et al.   CARBOHYDRATE RESEARCH

Measures to Control and PreventClostridium difficileInfection

(2008) Dale N. Gerding et al.   CLINICAL INFECTIOUS DISEASES